Analysis of Beneficiaries from Trump's Weight Loss Medication Price Reduction

During a White House briefing, President Trump introduced a new initiative aimed at making weight management medications more economical. Trump revealed that pharmaceutical giants Eli Lilly and Novo Nordisk are committed to reducing the cost of their well-known GLP-1 drugs.

Insight from Dr. Céline Gounder on Cost Reductions

CBS News' medical specialist, Dr. Céline Gounder, delved into the specifics of who could potentially benefit from the price decrease in these medications, pinpointing certain demographics and health groups that might gain improved access.